-
2
-
-
77954887019
-
The pharmaceutical price regulation scheme. An OFT market study
-
Office of Fair Trading, February
-
Office of Fair Trading.: The pharmaceutical price regulation scheme. An OFT market study. Office of Fair Trading, February (2007)
-
(2007)
Office of Fair Trading
-
-
-
4
-
-
0242571874
-
Heälso-och sjukvården behöver kunskap om hur befolkningen värderar hälsan
-
Persson, U., Hjelmgren, J.: Heälso-och sjukvården behöver kunskap om hur befolkningen värderar hälsan. Läkartidningen. 100(Nr 43), 3436-3437 (2003)
-
(2003)
Läkartidningen.
, vol.100
, Issue.43
, pp. 3436-3437
-
-
Persson, U.1
Hjelmgren, J.2
-
5
-
-
34248656917
-
Betalningsviljan för ett kvalitetsjusterat levnadsår-en pilotstudie
-
Hjalte, K., Hjelmgren, J., Johansson, F., Persson, U.: Betalningsviljan för ett kvalitetsjusterat levnadsår-en pilotstudie. IHE, E-rapport (2005)
-
(2005)
IHE, E-rapport
-
-
Hjalte, K.1
Hjelmgren, J.2
Johansson, F.3
Persson, U.4
-
6
-
-
77954888365
-
Kostnadsutveckling i svensk sjukvård relaterad till övervikt och fetma-några scenarier. Vårdens resursbehov och utmaningar på längre sikt
-
Persson, U., Svensson, M., Ödegaard, K.: Kostnadsutveckling i svensk sjukvård relaterad till övervikt och fetma-några scenarier. Vårdens resursbehov och utmaningar på längre sikt. Landstingsförbundet, Stockholm (2004)
-
(2004)
Landstingsförbundet, Stockholm
-
-
Persson, U.1
Svensson, M.2
Ödegaard, K.3
-
7
-
-
27744491391
-
Obesity, survival and hospital costs-findings from a screening project in Sweden
-
Borg, S., Persson, U., Ödegaard, K., Berglund, G., Nilsson, J.-Å ., Nilsson, P.: Obesity, survival and hospital costs-findings from a screening project in Sweden. Value Health. 8(5), 562-571 (2005)
-
(2005)
Value Health.
, vol.8
, Issue.5
, pp. 562-571
-
-
Borg, S.1
Persson, U.2
Ödegaard, K.3
Berglund, G.4
Nilsson, J.-Å.5
Nilsson, P.6
-
8
-
-
39649116638
-
The Swedish cost burden of overweight and obesity-evaluated with the PAR approach and a statistical modelling approach
-
Ödegaard, K., Borg, S., Persson, U., Svensson, M. The Swedish cost burden of overweight and obesity-evaluated with the PAR approach and a statistical modelling approach. Int. J. Pediatr. Obes. 3, 51-57 (2008)
-
(2008)
Int. J. Pediatr. Obes.
, Issue.3
, pp. 51-57
-
-
Ödegaard, K.1
Borg, S.2
Persson, U.3
Svensson, M.4
-
9
-
-
14944339043
-
Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data
-
Bagust, A., Sophi, B.: Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ. 14, 217-230 (2005)
-
(2005)
Health Econ.
, vol.14
, pp. 217-230
-
-
Bagust, A.1
Sophi, B.2
-
10
-
-
27744569367
-
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): Descriptive analysis from the first 20, 000 subjects
-
Currie, C.J., McEwan, P., Burgess, J., Peters, J.R., Patel, T.C., Dixon, S.: The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20, 000 subjects. Value Health. 8(5), 581-590 (2006)
-
(2006)
Value Health.
, vol.8
, Issue.5
, pp. 581-590
-
-
Currie, C.J.1
McEwan, P.2
Burgess, J.3
Peters, J.R.4
Patel, T.C.5
Dixon, S.6
-
11
-
-
37249083878
-
Long term pharmacotherapy for obesity and overweight: Updated metaanalysis
-
Rucker, D., Padwal, R., Li, S.K., Curioni, C., Lau, D.C.: Long term pharmacotherapy for obesity and overweight: updated metaanalysis. Br. Med. J. 335, 1194-1199 (2007)
-
(2007)
Br. Med. J.
, vol.335
, pp. 1194-1199
-
-
Rucker, D.1
Padwal, R.2
Li, S.K.3
Curioni, C.4
Lau, D.C.5
-
12
-
-
17144382751
-
Effects of the cannobinoid-1 receptor blocker Acomplia on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIOEurope study
-
Van Gaal, Luc F., et al.: Effects of the cannobinoid-1 receptor blocker Acomplia on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIOEurope study. Lancet. 365(9468), 1389-1397 (2005)
-
(2005)
Lancet.
, vol.365
, Issue.9468
, pp. 1389-1397
-
-
Van Gaal Luc, F.1
-
13
-
-
27844463517
-
Effects of Acomplia on metabolic risk factors in overweight patients with dyslipidemia
-
Despres, J.P., et al.: Effects of Acomplia on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353(20), 2121-2134 (2005)
-
(2005)
N. Engl. J. Med.
, vol.353
, Issue.20
, pp. 2121-2134
-
-
Despres, J.P.1
-
14
-
-
32644441249
-
Effect of Acomplia, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial
-
Pi-Sunyer, F.X., et al.: Effect of Acomplia, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. 295(7), 761-775 (2006)
-
(2006)
JAMA.
, vol.295
, Issue.7
, pp. 761-775
-
-
Pi-Sunyer, F.X.1
-
16
-
-
3042622492
-
Systematic review of long-term effects and economic consequences of treatment for obesity and implication for health improvement
-
Avenell, A., et al.: Systematic review of long-term effects and economic consequences of treatment for obesity and implication for health improvement. Health technology assessment, vol 8, No 21 (2004)
-
(2004)
Health Technology Assessment
, vol.8
, Issue.21
-
-
Avenell, A.1
-
17
-
-
77954886628
-
Consumption and production by age in Sweden: Basic facts and health economic implication
-
Dissertation for the degree of Doctor of Philosophy at the Stockholm School of Economics. EFI, Stockholm, Sweden
-
Ekman, Mattias. Consumption and production by age in Sweden: Basic facts and health economic implication. In Ekman M. Studies in health economics: Modelling and data analysis of costs and survival. Dissertation for the degree of Doctor of Philosophy at the Stockholm School of Economics. EFI, Stockholm, Sweden (2002)
-
(2002)
Ekman M. Studies in Health Economics: Modelling and data Analysis of Costs and Survival
-
-
Mattias, E.1
-
18
-
-
77954887776
-
-
Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 1023/2006
-
Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 1023/2006
-
-
-
-
19
-
-
77954888045
-
-
Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 59/2008
-
Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 59/2008
-
-
-
-
20
-
-
77954886915
-
-
Läkemedelsförmånsnämnden (LFN), Beslut (Decision) Stockholm 34/2002
-
Läkemedelsförmånsnämnden (LFN) Beslut (Decision) Stockholm 34/2002
-
-
-
-
21
-
-
33747870163
-
Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old
-
Adams Kenneth, F., et al.: Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 355(8), 763-778 (2006)
-
(2006)
N. Engl. J. Med.
, vol.355
, Issue.8
, pp. 763-778
-
-
Adams Kenneth, F.1
-
22
-
-
15444346214
-
Model of complications of NIDDM: I. Model construction and assumptions
-
Eastman, R., Javitt, J., Herman, W., Dasbach, A., Zbrozek, A., Dong, F., Manninen, D., Garfield, S., Copley-Merriman, C., Maier, W., Eastman, J., Kotsanos, J., Cowie, C., Harris, M.: Model of Complications of NIDDM: I. Model Construction and Assumptions. Diabetes Care. 20, 725-734 (1997)
-
(1997)
Diabetes Care.
, Issue.20
, pp. 725-734
-
-
Eastman, R.1
Javitt, J.2
Herman, W.3
Dasbach, A.4
Zbrozek, A.5
Dong, F.6
Manninen, D.7
Garfield, S.8
Copley-Merriman, C.9
Maier, W.10
Eastman, J.11
Kotsanos, J.12
Cowie, C.13
Harris, M.14
-
23
-
-
11144298966
-
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: The United Kingdom prospective diabetes study (UKPDS) Outcomes model (UKPDS no. 68)
-
Clarke, P., Gray, A., Briggs, A., Farmer, A., Fenn, P., Stevens, R., Mathews, D., Stratton, I., Holman, R.: A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47, 1747-1759 (2004)
-
(2004)
Diabetologia
, vol.47
, pp. 1747-1759
-
-
Clarke, P.1
Gray, A.2
Briggs, A.3
Farmer, A.4
Fenn, P.5
Stevens, R.6
Mathews, D.7
Stratton, I.8
Holman, R.9
-
25
-
-
77954888249
-
-
FASS, assumed to remain unchanged for 2006
-
FASS. http://www.fass.se/, assumed to remain unchanged for 2006 (2005)
-
(2005)
-
-
-
26
-
-
0038579421
-
Estimation of ten year risk of fatal cardiovascular disease in Europe: The SCORE project
-
for the SCORE project group
-
Conroy, R.M., for the SCORE project group, et al.: Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. EUR. Heart J. 24, 987-1003 (2003)
-
(2003)
EUR. Heart J.
, vol.24
, pp. 987-1003
-
-
Conroy, R.M.1
-
27
-
-
0033547217
-
Lifetime health and economic consequence of obesity
-
Thompson, D., Edelsberg, J., Colditz, G.A., Bird, A.P., Oster, G.: Lifetime health and economic consequence of obesity. Arch. Int. Med. 159, 2177-2833 (1999)
-
(1999)
Arch. Int. Med.
, vol.159
, pp. 2177-2833
-
-
Thompson, D.1
Edelsberg, J.2
Colditz, G.A.3
Bird, A.P.4
Oster, G.5
-
28
-
-
0033823270
-
Coronary hearth disease incidence in northern and southern European population: A reanalysis of seven countries study for a European coronary risk chart
-
Menotti, A., Lanti, M., Puddu, P.E., et al.: Coronary hearth disease incidence in northern and southern European population: a reanalysis of seven countries study for a European coronary risk chart. Heart. 84, 238-244 (2000)
-
(2000)
Heart.
, vol.84
, pp. 238-244
-
-
Menotti, A.1
Lanti, M.2
Puddu, P.E.3
-
29
-
-
0033191062
-
Reduction in incidence of diabetes, hypertension and lip disturbances after intentional weight loss induced by bariatric surgery: The SOS intervention study
-
Sjöström, C.D., Lissner, Ö., Wedel, H., Sjöström, L.: Reduction in incidence of diabetes, hypertension and lip disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes. Res. 7, 477-484 (1999)
-
(1999)
Obes. Res.
, Issue.7
, pp. 477-484
-
-
Sjöström, C.D.1
Lissner, Ö.2
Wedel, H.3
Sjöström, L.4
-
30
-
-
1642443523
-
Cost-effectiveness of sibutramine in the treatment of obesity
-
Warren, E., Brennan, A., Akehurst, R.: Cost-effectiveness of sibutramine in the treatment of obesity. Med. Decis. Making. 24, 9-18 (2004)
-
(2004)
Med. Decis. Making.
, vol.24
, pp. 9-18
-
-
Warren, E.1
Brennan, A.2
Akehurst, R.3
-
31
-
-
77954888032
-
Economic evaluation of diabetic glycemic control: Literature review of epidemiology and treatment costs in Sweden
-
Norinder, A., et al.: Economic evaluation of diabetic glycemic control: literature review of epidemiology and treatment costs in Sweden. Internal rapport IHE (1998)
-
(1998)
Internal Rapport IHE
-
-
Norinder, A.1
-
32
-
-
77954887227
-
Priser och ersättning för sydöstra sjukvårdsregionen 2005
-
Samverkansnämnden sydöstra sjukvårdsregionen
-
Samverkansnämnden sydöstra sjukvårdsregionen. Priser och ersättning för sydöstra sjukvårdsregionen 2005 (Prices and Reimbursements in the South-East Swedish Health Care Region), p 60 (2005)
-
(2005)
Prices and Reimbursements in the South-East Swedish Health Care Region
, pp. 60
-
-
-
33
-
-
0032798432
-
Cost of coronary heart disease and stroke: The case of Sweden
-
Zethraeus, N., et al.: Cost of coronary heart disease and stroke: the case of Sweden. J. Intern. Med. 246, 151-159 (1999)
-
(1999)
J. Intern. Med.
, vol.246
, pp. 151-159
-
-
Zethraeus, N.1
-
34
-
-
4043050724
-
Cost of stroke in Sweden: An incidence estimate
-
Ghatnekar, O., et al.: Cost of stroke in Sweden: an incidence estimate. Int. J. Technol. Assess. Health Care. 20(3), 375-380 (2004)
-
(2004)
Int. J. Technol. Assess. Health Care.
, vol.20
, Issue.3
, pp. 375-380
-
-
Ghatnekar, O.1
|